Looking for a biopharma job in New York? Check out the BioSpace list of seven companies hiring life sciences professionals ...

Patritumab deruxtecan was unable to significantly improve overall survival in patients with locally advanced or metastatic ...

Teos expects to absorb nearly $25 million in one-time costs for severance and termination payments. The biotech had 173 ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

It’s called the peak-end rule. People remember two things most about an experience: the most emotionally intense moment and ...

The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.

Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...

Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the ...

In a video posted to social media on Tuesday, HHS Secretary Robert F. Kennedy, Jr. claimed that there is a lack of clinical ...

The layoffs will take effect on July 22 and particularly target those working in sales, data engineering and product ...

InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.

Rouzbeh Haghighat was serving on the board of Chinook Therapeutics at the time of the Novartis acquisition and, according to ...